 |
|
Influencing Factors and Predictors of Early Response in Schizophrenia Patients Receiving the Paliperidone Extended-Release Tablets (Paliperidone ER)
Seung-Ho Jung, Jin-Sang Yoon, Yong-Min Ahn, Yong-Sik Kim, Chul-Eung Kim
Psychiatry Investig. 2013;10(4):407-416. Published online 2013 Dec 16 DOI: https://doi.org/10.4306/pi.2013.10.4.407
|
|
Dose Adjustment Model of Paliperidone in Patients With Acute Schizophrenia: A post hoc Analysis of an Open-Label, Single-Arm Multicenter Study
Tianmei Si, Ling Sun, Yilong Zhang, Lili Zhang
Frontiers in Psychiatry.2021;[Epub] CrossRef A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone
Georgios Schoretsanitis, Edoardo Spina, Christoph Hiemke, Jose de Leon
Expert Review of Clinical Pharmacology.2018; 11(6): 625. CrossRef Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study
Luis Molina, Byron Recinos, Bezner Paz, Mauricio Rovelo, Fanny Elizabeth Elias Rodriguez, José Calderón, Arturo Arellano, Santiago Pomata, María Verónica Rey, Santiago Perez-Lloret
Clinical Drug Investigation.2016; 36(6): 491. CrossRef
|